Literature DB >> 19112051

Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for determination of isoniazid in human plasma.

Liusheng Huang1, Florence Marzan, Anura L Jayewardene, Patricia S Lizak, Xiaohua Li, Francesca T Aweeka.   

Abstract

An LC-MS/MS method for the determination of isoniazid in human plasma was developed and validated. Human plasma aliquots of 100 microL were used for analysis. The assay used nialamide as the internal standard. The calibration curve concentration range was 50-10,000 ng/mL. Sample preparation utilized protein precipitation, and the supernatant was directly injected onto silica column without reconstitution. The recovery was over 90% and matrix effect was negligible. The method is simple and fast, which is advantageous in respect to instability of isoniazid in human plasma and loss on reconstitution due to its low molecular weight.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19112051      PMCID: PMC3032609          DOI: 10.1016/j.jchromb.2008.12.024

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

1.  Determination of rifampicin, isoniazid and pyrazinamide by high performance liquid chromatography after their simultaneous extraction from plasma.

Authors:  P J Smith; J van Dyk; A Fredericks
Journal:  Int J Tuberc Lung Dis       Date:  1999-11       Impact factor: 2.373

2.  Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.

Authors:  Sang Hoon Song; Sun Hee Jun; Kyoung Un Park; Yeomin Yoon; Jae Ho Lee; Jin Q Kim; Junghan Song
Journal:  Rapid Commun Mass Spectrom       Date:  2007       Impact factor: 2.419

3.  Spectrophotofluorometric assay for isoniazid and acetyl isoniazid in plasma adapted to pediatric studies.

Authors:  W A Olson; P G Dayton; Z H Israili; A W Pruitt
Journal:  Clin Chem       Date:  1977       Impact factor: 8.327

4.  Sensitive liquid chromatographic technique to measure isoniazid in alveolar cells, bronchoalveolar lavage and plasma in HIV-infected patients.

Authors:  T Delahunty; B Lee; J E Conte
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-02-13

5.  A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of isoniazid and ethambutol in human plasma.

Authors:  Xiaoyan Chen; Bo Song; Hongjian Jiang; Kate Yu; Dafang Zhong
Journal:  Rapid Commun Mass Spectrom       Date:  2005       Impact factor: 2.419

6.  Quantification of isoniazid and acetylisoniazid in rat plasma and alveolar macrophages by liquid chromatography-tandem mass spectrometry with on-line extraction.

Authors:  Ka-yun Ng; Huiyu Zhou; Yan Ling Zhang; Brooks Hybertson; Theodore Randolph; Uwe Christians
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-10-27       Impact factor: 3.205

7.  Direct injection of solid-phase extraction eluents onto silica columns for the analysis of polar compounds isoniazid and cetirizine in plasma using hydrophilic interaction chromatography with tandem mass spectrometry.

Authors:  Austin C Li; Heiko Junga; Wilson Z Shou; Matthew S Bryant; Xiang-yu Jiang; Weng Naidong
Journal:  Rapid Commun Mass Spectrom       Date:  2004       Impact factor: 2.419

Review 8.  Clinical pharmacokinetics of isoniazid.

Authors:  W W Weber; D W Hein
Journal:  Clin Pharmacokinet       Date:  1979 Nov-Dec       Impact factor: 6.447

Review 9.  Present status of chemotherapy for tuberculosis.

Authors:  J H Grosset
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr
  9 in total
  5 in total

1.  Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometry.

Authors:  M Lisa Manier; Michelle L Reyzer; Anne Goh; Veronique Dartois; Laura E Via; Clifton E Barry; Richard M Caprioli
Journal:  J Am Soc Mass Spectrom       Date:  2011-05-13       Impact factor: 3.109

2.  Determination of melphalan in human plasma by UPLC-UV method.

Authors:  Liusheng Huang; Vincent Cheah; Danna Chan; Florence Marzan; Christopher C Dvorak; Francesca T Aweeka; Janel Long-Boyle
Journal:  Cancer Chemother Pharmacol       Date:  2019-02-13       Impact factor: 3.333

3.  Potential to Use Fingerprints for Monitoring Therapeutic Levels of Isoniazid and Treatment Adherence.

Authors:  Mahado Ismail; Catia Costa; Katherine Longman; Mark A Chambers; Sarah Menzies; Melanie J Bailey
Journal:  ACS Omega       Date:  2022-04-21

4.  Simultaneous determination of fludarabine and clofarabine in human plasma by LC-MS/MS.

Authors:  Liusheng Huang; Patricia Lizak; Christopher C Dvorak; Francesca Aweeka; Janel Long-Boyle
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-02       Impact factor: 3.205

5.  Quantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active Tuberculosis.

Authors:  Roy Gerona; Anita Wen; Aaron T Chin; Catherine A Koss; Peter Bacchetti; John Metcalfe; Monica Gandhi
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.